Exchange: OTC·Updated 04:00 PM EST

About ENTBD

About

Entheon Biomedical Corp. operates as a biotechnology research and development company. The firm engages in developing and commercializing dimethyltryptamine based psychedelic therapeutic products. Its therapies aim to treat addiction and substance use disorders. The company was founded on April 6, 2010 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

Advertisement|Remove ads.